Nargiza Kadirova

Mrs. Nargiza Kadirova


Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 February 2023 in Science and Innovations in Medicine
Verified
Journal Article
Open access
PDF file
NNNargiza Nurillaeva
Nargiza Nurillaeva
NKNargiza Kadirova
Nargiza Kadirova
Muborakkhon ZokirovaMuborakkhon Zokirova
Muborakkhon Zokirova
Aim to determine the quantitative content of the tissue plasminogen activator inhibitor type 1 (PAI-1) and to determine its relationship with risk factors for coronary artery disease. Material and methods. The study included 67 male and female patients (36 men and 31 women) with coronary artery disease (CAD) and stable angina classes II-IV with the presence of hypertension. The mean age of the patients was 60.20.76 years. In all patients, clinical and anamnestic data were collected during the examination. For pain assessment, we used a verbal scale. We registered the anthropometric data and body mass index. Biochemical and instrumental methods of research were used according to the standards for diagnosing CAD. We assessed the occurrence of risk factors in patients included in the study. A complex of general clinical laboratory and instrumental tests was used, as well as the method of enzyme immunoassay ELISA, which determined the level of PAI-1, platelet aggregation activity, renin, aldosterone, cortisol and endothelin. Results. The group of patients demonstrated a reliable elevation of PAI-1 plasma level. Compared with practically healthy people, the level of this biomarker was 1.6 times higher in patients with coronary artery disease. A significant elevation of PAI-1 level indicates an increased risk of endothelial and hemostasiological disorders in patients, which, in turn, increases the risk of thrombogenic complications. The study revealed the correlation of PAI-1 protein in CAD patients with such risk factors as mixed anxiety-depressive disorder, smoking, hypertension, obesity, and hypercholesterolemia.

9 July 2026 in Preprints.org
Verified
Preprint
Open access
PDF file
LZLazzat Zhussupbekova
Lazzat Zhussupbekova
DNDildora Nasredinova
Dildora Nasredinova
NNNargiza Nurillaeva
Nargiza Nurillaeva
NKNargiza Kadirova
Nargiza Kadirova
AMAziz Mominov
Aziz Mominov
SKShoxista Kurbonova
Shoxista Kurbonova
This study aimed to examine the distribution of allele and genotype frequencies of the β-fibrinogen -455G/A polymorphism among patients with ischemic heart disease (IHD) and to evaluate fibrinogen levels according to genotype. Materials and methods: A total of 135 patients with primarily stable angina pectoris were included, comprising 57 men and 78 women, hospitalised in the First Cardiology Department of the Multidisciplinary Clinic at Tashkent Medical University. The mean age was 58.0 ± 1.2 years (range: 42–66 years). The control group consisted of 40 apparently healthy individuals. Results: In the main group, genotype frequencies were G/G – 53.3%, G/A – 22.2%, and A/A – 24.4%. In the control group, the respective frequencies were 57.5%, 22.5%, and 20.0%. The lowest fibrinogen levels were found in G/G genotype carriers, while the highest were observed in A/A genotype carriers. Conclusion: Although allele frequencies were similar between groups, a marked genotype-dependent effect on fibrinogen levels was identified. These findings align with published evidence that the A allele is associated with increased fibrinogen synthesis and a more prothrombotic phenotype.

10 November 2025 in Science and Innovations in Medicine
Verified
Journal Article
Open access
NKNargiza Kadirova
Nargiza Kadirova
NNNargiza Nurillaeva
Nargiza Nurillaeva
НМНуриллаева Наргиза Мухтархановна
Нуриллаева Наргиза Мухтархановна
VPVictoria В. Petrova
Victoria В. Petrova
ELEkaterina S. Lapteva
Ekaterina S. Lapteva
VSVladimir A. Shumkov
Vladimir A. Shumkov
Aim – to study the distribution of allele frequencies of the polymorphic marker 4G(-675)5G of the PAI-1 gene among patients with coronary heart disease and individuals with risk factors for the development of coronary heart disease. Material and methods. The study included 63 patients with diagnosed coronary heart disease, especially with stable angina (48 men and 15 women) hospitalized in the 1st Cardiology Department of the Multidisciplinary Clinic of the Tashkent Medical Academy. The average age of patients was 56.8 ± 6.40 years (42-66 years old). The state of hypercoagulability was assessed by measures of polymorphism gene of PAI-1 and plasma level of PAI-1. Results. The assessment of the frequency of various variants of the 4G(-675)5G polymorphic marker of the PAI-1 gene showed that differences in the distribution of the 5G/5G, 4G/5G, 4G/4G genotypes depending on the functional class of coronary artery disease are not statistically significant, since the chi-square test value was χ2 = 1.85 (p 0.05). Based on the obtained results, it can be assumed that the presence of hetero- and homozygous variants of the 4G allele of the PAI-1 gene does not affect the severity of the disease, in particular, the functional class of stable angina. Conclusion. The 4G/5G polymorphism of the PAI-1 gene was significantly associated with the risk of coronary heart disease in the Uzbek population. When stratified by angina functional class, the results showed that the 4G/5G polymorphism is associated with an increased risk of coronary heart disease and higher plasma PAI-1 levels.